Shanghai Kehua Bio-engineering Co Ltd Class A 002022
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥5.91
- Day Range
- ¥5.95–6.26
- 52-Week Range
- ¥5.05–11.85
- Bid/Ask
- ¥6.16 / ¥6.17
- Market Cap
- ¥3.17 Bil
- Volume/Avg
- 12.0 Mil / 7.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.62
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,151
- Website
- http://www.skhb.com
Comparables
Valuation
|
Metric
|
002022
|
301060
|
688298
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 29.68 | — |
Price/Book Value | 0.79 | 2.15 | 0.89 |
Price/Sales | 1.62 | 2.24 | 8.32 |
Price/Cash Flow | 21.46 | 48.96 | — |
Price/Earnings
002022
301060
688298
Financial Strength
|
Metric
|
002022
|
301060
|
688298
|
|---|---|---|---|
Quick Ratio | 3.44 | 2.66 | 3.58 |
Current Ratio | 4.95 | 3.27 | 4.05 |
Interest Coverage | −6.69 | −9.75 | −34.79 |
Quick Ratio
002022
301060
688298
Profitability
|
Metric
|
002022
|
301060
|
688298
|
|---|---|---|---|
Return on Assets (Normalized) | −5.20% | −4.28% | −7.14% |
Return on Equity (Normalized) | −8.51% | −7.03% | −8.68% |
Return on Invested Capital (Normalized) | −5.68% | −5.26% | −9.77% |
Return on Assets
002022
301060
688298
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Cwhfvbld | Qjjyy | $195.6 Bil | |||
| Stryker Corp
SYK
| Slxgznssj | Pxhq | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Zrhlwfb | Prvzjb | $122.7 Bil | |||
| Medtronic PLC
MDT
| Hszhddtdj | Wvsdtwj | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Mhtbmrkd | Bsrpytk | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Thms | Szysl | $30.7 Bil | |||
| DexCom Inc
DXCM
| Jckwqlhbgh | Zszp | $27.0 Bil | |||
| Steris PLC
STE
| Rrpmhsp | Lvfjg | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Pzbsznvjtv | Cdyv | $22.0 Bil | |||
| Insulet Corp
PODD
| Vpgfccfq | Tpbgvq | $16.3 Bil |
United States